• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FAP阳性细胞系球体作为筛选影响FAP表达药物的模型。

Spheroids of FAP-Positive Cell Lines as a Model for Screening Drugs That Affect FAP Expression.

作者信息

Pleshkan Victor V, Zinovyeva Marina V, Antonova Dina V, Alekseenko Irina V

机构信息

Gene Immunooncotherapy Group, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia.

National Research Center "Kurchatov Institute", 123182 Moscow, Russia.

出版信息

Biomedicines. 2023 Jul 18;11(7):2017. doi: 10.3390/biomedicines11072017.

DOI:10.3390/biomedicines11072017
PMID:37509656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10377737/
Abstract

Fibroblast activation protein has a unique expression profile that manifests mainly in wounds and tumors, which anticipates it as an encouraging and selective target for anticancer therapy. However, research of the therapeutic potential of FAP is limited both by legal restraints when working in vivo and by the difficulty of obtaining standardized primary cultures of FAP-positive cancer-associated fibroblasts due to their high heterogeneity. We found that 3D spheroids of FAP-positive cell lines could serve as robust and convenient models of FAP expression, in contrast to monolayers. By exposing such spheroids to various factors and compounds, it is possible to study changes in FAP expression, which are easily detected by confocal microscopy. FAP expression increases under the influence of the TGFβ, does not depend on pH, and decreases during hypoxia and starvation. We believe that the proposed model could be used to organize large-scale high-throughput screening of drugs that target FAP expression.

摘要

成纤维细胞活化蛋白具有独特的表达模式,主要表现在伤口和肿瘤中,这使其有望成为抗癌治疗中一个令人鼓舞的选择性靶点。然而,FAP治疗潜力的研究受到体内研究时的法律限制,以及由于FAP阳性癌相关成纤维细胞高度异质性而难以获得标准化原代培养物的限制。我们发现,与单层细胞相比,FAP阳性细胞系的3D球体可作为FAP表达的强大且便捷的模型。通过将此类球体暴露于各种因子和化合物,可以研究FAP表达的变化,通过共聚焦显微镜很容易检测到这些变化。FAP表达在TGFβ的影响下增加,不依赖于pH值,在缺氧和饥饿期间降低。我们相信,所提出的模型可用于组织针对FAP表达的药物的大规模高通量筛选。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/3cf33a752f87/biomedicines-11-02017-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/0cd1bcc7c6e5/biomedicines-11-02017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/1f16f1a3b0fe/biomedicines-11-02017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/c618e5ab92b6/biomedicines-11-02017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/43c6de72cbfd/biomedicines-11-02017-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/3cf33a752f87/biomedicines-11-02017-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/0cd1bcc7c6e5/biomedicines-11-02017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/1f16f1a3b0fe/biomedicines-11-02017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/c618e5ab92b6/biomedicines-11-02017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/43c6de72cbfd/biomedicines-11-02017-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/876f/10377737/3cf33a752f87/biomedicines-11-02017-g005.jpg

相似文献

1
Spheroids of FAP-Positive Cell Lines as a Model for Screening Drugs That Affect FAP Expression.FAP阳性细胞系球体作为筛选影响FAP表达药物的模型。
Biomedicines. 2023 Jul 18;11(7):2017. doi: 10.3390/biomedicines11072017.
2
Analysis of the expression of FAP-α protein in 2D-keloid fibroblast cultures and in 3D models of keloid.分析 2D 瘢痕成纤维细胞培养物和瘢痕的 3D 模型中 FAP-α 蛋白的表达。
J Cosmet Dermatol. 2022 Aug;21(8):3561-3566. doi: 10.1111/jocd.14667. Epub 2021 Dec 12.
3
Expression of the FAP gene in non-fibroblast human cell lines. Development of cancer-associated fibroblast models.FAP基因在非成纤维细胞人细胞系中的表达。癌症相关成纤维细胞模型的建立。
Dokl Biochem Biophys. 2016 Sep;470(1):319-321. doi: 10.1134/S1607672916050033. Epub 2016 Nov 6.
4
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.针对肿瘤基质,使用一种分泌成纤维细胞活化蛋白靶向双特异性 T 细胞衔接子的溶瘤腺病毒。
J Immunother Cancer. 2019 Jan 25;7(1):19. doi: 10.1186/s40425-019-0505-4.
5
Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.转化生长因子 β-1 调控胶质母细胞瘤微环境中成纤维细胞激活蛋白的表达。
Int J Mol Sci. 2021 Jan 21;22(3):1046. doi: 10.3390/ijms22031046.
6
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy.类风湿关节炎患者成纤维细胞激活蛋白的靶向治疗:成像和体外光动力治疗。
Rheumatology (Oxford). 2022 Jul 6;61(7):2999-3009. doi: 10.1093/rheumatology/keab664.
7
Evaluating near-infrared photoimmunotherapy for targeting fibroblast activation protein-α expressing cells in vitro and in vivo.评估近红外光免疫疗法靶向体外和体内表达成纤维细胞激活蛋白-α的细胞。
Cancer Sci. 2023 Jan;114(1):236-246. doi: 10.1111/cas.15601. Epub 2022 Oct 21.
8
TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.TGF-β1 通过 FAP/VCAN 轴在膀胱癌细胞中主导基质成纤维细胞介导的 EMT。
J Transl Med. 2023 Jul 17;21(1):475. doi: 10.1186/s12967-023-04303-3.
9
Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin.间充质和神经外胚层来源的正常及转化细胞中成纤维细胞活化蛋白的调控与异源结构
Cancer Res. 1993 Jul 15;53(14):3327-35.
10
Scaffold-Free Coculture Spheroids of Human Colonic Adenocarcinoma Cells and Normal Colonic Fibroblasts Promote Tumorigenicity in Nude Mice.人结肠腺癌细胞与正常结肠成纤维细胞的无支架共培养球体促进裸鼠肿瘤发生
Transl Oncol. 2016 Feb;9(1):79-88. doi: 10.1016/j.tranon.2015.12.001.

本文引用的文献

1
Fibroblasts as Turned Agents in Cancer Progression.成纤维细胞作为癌症进展中的转化因子。
Cancers (Basel). 2023 Mar 28;15(7):2014. doi: 10.3390/cancers15072014.
2
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.肿瘤进展和免疫逃逸中的细胞外基质重塑:从机制到治疗。
Mol Cancer. 2023 Mar 11;22(1):48. doi: 10.1186/s12943-023-01744-8.
3
The advent of immune stimulating CAFs in cancer.癌症中免疫刺激癌相关成纤维细胞的出现。
Nat Rev Cancer. 2023 Apr;23(4):258-269. doi: 10.1038/s41568-023-00549-7. Epub 2023 Feb 17.
4
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.癌症相关成纤维细胞中的信号通路:最新进展和未来展望。
Cancer Commun (Lond). 2023 Jan;43(1):3-41. doi: 10.1002/cac2.12392. Epub 2022 Nov 24.
5
Targeting the tumor stroma for cancer therapy.针对肿瘤基质的癌症治疗。
Mol Cancer. 2022 Nov 2;21(1):208. doi: 10.1186/s12943-022-01670-1.
6
Biological heterogeneity of primary cancer-associated fibroblasts determines the breast cancer microenvironment.原发性癌相关成纤维细胞的生物学异质性决定乳腺癌微环境。
Am J Cancer Res. 2022 Sep 15;12(9):4411-4427. eCollection 2022.
7
Modulating cancer-stroma crosstalk by a nanoparticle-based photodynamic method to pave the way for subsequent therapies.通过基于纳米颗粒的光动力方法调节癌症-基质相互作用,为后续治疗铺平道路。
Biomaterials. 2022 Oct;289:121813. doi: 10.1016/j.biomaterials.2022.121813. Epub 2022 Sep 17.
8
Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review.基于成纤维细胞激活蛋白的癌症研究治疗学:最新综述。
Theranostics. 2022 Jan 9;12(4):1557-1569. doi: 10.7150/thno.69475. eCollection 2022.
9
TGF-β and Cancer Immunotherapy.TGF-β 与癌症免疫疗法。
Biol Pharm Bull. 2022;45(2):155-161. doi: 10.1248/bpb.b21-00966.
10
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress.基于放射性标记成纤维细胞激活蛋白抑制剂的癌症成像与治疗新前沿:理性回顾与当前进展
Pharmaceuticals (Basel). 2021 Oct 5;14(10):1023. doi: 10.3390/ph14101023.